• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143

4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester (CAS No. 873458-37-8): A Comprehensive Overview

4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester (CAS No. 873458-37-8) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as methyl 3-(4-fluorophenyl)picolinate, is characterized by its unique structure, which combines a pyridine ring with a fluorinated phenyl group and a methyl ester moiety. This combination of functional groups imparts a range of chemical and biological properties that make it a valuable intermediate in the synthesis of various pharmaceuticals and agrochemicals.

The molecular formula of 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester is C₁₂H₁₀FN₂O₂, and its molecular weight is approximately 231.21 g/mol. The compound is typically synthesized through the esterification of 3-(4-fluorophenyl)picolinic acid with methanol in the presence of an acid catalyst. This reaction is well-documented in the literature and is known for its high yield and purity.

In recent years, 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester has been extensively studied for its potential applications in the development of novel therapeutic agents. One of the key areas of interest is its use as an intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs). SSRIs are a class of antidepressants that work by increasing the levels of serotonin in the brain, thereby improving mood and reducing symptoms of depression and anxiety. The presence of the fluorinated phenyl group in methyl 3-(4-fluorophenyl)picolinate enhances its lipophilicity, which can improve its ability to cross the blood-brain barrier and enhance its therapeutic efficacy.

Beyond its role in SSRI synthesis, 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester has also shown promise in the development of anti-inflammatory agents. Inflammation is a complex biological response to harmful stimuli such as pathogens, damaged cells, or irritants. Compounds that can effectively modulate inflammatory pathways have significant therapeutic potential for treating a wide range of diseases, including arthritis, asthma, and inflammatory bowel disease. Recent studies have demonstrated that derivatives of methyl 3-(4-fluorophenyl)picolinate exhibit potent anti-inflammatory activity by inhibiting key enzymes involved in the production of pro-inflammatory mediators such as prostaglandins and leukotrienes.

The pharmacological properties of 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester are further enhanced by its stability under various conditions. The compound is stable at room temperature and can be stored for extended periods without significant degradation. This stability makes it an ideal candidate for large-scale synthesis and industrial applications. Additionally, the compound's solubility in common organic solvents such as methanol, ethanol, and dichloromethane facilitates its use in various chemical reactions and processes.

In terms of safety and handling, methyl 3-(4-fluorophenyl)picolinate should be managed with standard laboratory precautions to ensure safe handling and storage. It is recommended to use personal protective equipment (PPE) such as gloves and goggles when working with this compound to prevent skin contact and inhalation. The compound should be stored in a cool, dry place away from direct sunlight and incompatible materials.

The environmental impact of 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester is another important consideration. While there are no specific environmental regulations governing this compound at present, it is advisable to follow best practices for waste disposal to minimize any potential environmental impact. Proper disposal methods include incineration or neutralization before disposal to ensure that any residual compounds are rendered harmless.

In conclusion, 4-Pyridinecarboxylic acid, 3-(4-fluorophenyl)-, methyl ester (CAS No. 873458-37-8) is a highly versatile compound with significant potential applications in medicinal chemistry and pharmaceutical research. Its unique structure and favorable chemical properties make it an attractive intermediate for the synthesis of various therapeutic agents. Ongoing research continues to explore new avenues for its use in developing novel drugs with improved efficacy and safety profiles.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)